Department of Orthopaedic Surgery, University of Verona, Policlinico G.B. Rossi, 37134, Verona, Italy.
Radiol Med. 2010 Mar;115(2):261-71. doi: 10.1007/s11547-009-0431-5. Epub 2009 Aug 7.
The aim of this study was to assess retrospectively the safety and efficacy of combined radiofrequency (RF) and kyphoplasty (KP) in managing painful osteolytic metastases to vertebral bodies resistant to conservative treatments.
Eleven patients (9 women and 2 men; mean age 68 years; age range 58-82) with painful osteolytic vertebral body metastases unresponsive to conservative treatments underwent RF combined with KP under general anaesthesia. Primary neoplasms were kidney carcinoma (n=1), breast carcinoma (n=1), thyroid carcinoma (n=2) and multiple myeloma (n=7). Lesion levels were cervical (n=1), thoracic (n=9) and lumbar (n=1). Combined RF and KP was well-tolerated by all patients. The procedures were performed using fluoroscopic guidance and intraoperative neurophysiology monitoring. Pain relief with the visual analogue scale (VAS) pain score and analgesic consumption were evaluated before and after treatment.
No complication occurred. In one case, we observed an asymptomatic cement leakage. Pain significantly decreased after treatment: the mean VAS pain score before treatment was 8 (range 7-10) vs. 1.8 (range 0-3) and 1.9 (range 1-3), respectively, 72 h and 6 weeks after the treatment. Analgesic reduction was achieved in all patients.
RF combined with KP represents a potential alternative method for palliation of painful spinal osteolytic metastases in selected patients. The procedures are safe and provide pain relief with bone augmentation and improvement in quality of life.
本研究旨在回顾性评估射频(RF)联合球囊扩张椎体后凸成形术(KP)治疗对保守治疗无效的溶骨性骨转移疼痛性椎体病变的安全性和疗效。
11 名患者(9 名女性和 2 名男性;平均年龄 68 岁;年龄范围 58-82 岁)患有对保守治疗无反应的溶骨性椎体转移疼痛性病变,在全身麻醉下接受 RF 联合 KP 治疗。主要肿瘤为肾癌(n=1)、乳腺癌(n=1)、甲状腺癌(n=2)和多发性骨髓瘤(n=7)。病变水平为颈椎(n=1)、胸椎(n=9)和腰椎(n=1)。所有患者均能良好耐受联合 RF 和 KP 治疗。该程序在透视引导和术中神经生理学监测下进行。在治疗前后,使用视觉模拟量表(VAS)疼痛评分和镇痛药物消耗评估疼痛缓解情况。
无并发症发生。在 1 例中,我们观察到无症状的水泥渗漏。治疗后疼痛明显减轻:治疗前的平均 VAS 疼痛评分为 8(范围 7-10),治疗后 72 小时和 6 周时分别为 1.8(范围 0-3)和 1.9(范围 1-3)。所有患者均实现了镇痛药物的减少。
RF 联合 KP 是治疗选择患者的疼痛性溶骨性脊柱转移病变的一种潜在替代方法。该程序是安全的,通过骨增强和改善生活质量来缓解疼痛。